Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
B303060-1mg
|
1mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$157.90
|
|
|
B303060-5mg
|
5mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$652.90
|
|
| Product Name | Bevacizumab (anti-VEGF) |
|---|---|
| Synonyms | Anti-Human VEGF | Humanized Antibody | rhuMab VEGF, Avastin |
| Specifications & Purity | Moligand™, ≥95%, ~25mg/ml(in buffer,PH6.2) |
| Grade | Moligand™ |
| Product Description |
Bevacizumab is a humanized monoclonal antibody that binds to all VEGF-A with high affinity and specificity. |
| Concentration | ~25mg/ml(in buffer,PH6.2) |
|---|---|
| Storage Temp | Protected from light,Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| CAS | 216974-75-3 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Apr 07, 2025 | B303060 | |
| Certificate of Analysis | Apr 07, 2025 | B303060 | |
| Certificate of Analysis | Nov 05, 2024 | B303060 | |
| Certificate of Analysis | Nov 05, 2024 | B303060 | |
| Certificate of Analysis | Aug 26, 2022 | B303060 | |
| Certificate of Analysis | Aug 26, 2022 | B303060 |
| 1. Wenjuan Huang, Liwen Wang, Ruhui Yang, Ronggui Hu, Qinxiang Zheng, Xingjie Zan. (2022) Combined delivery of small molecule and protein drugs as synergistic therapeutics for treating corneal neovascularization by a one-pot coassembly strategy. Materials Today Bio, 17 (100456). |